Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
about
A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin SystemsAngiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in miceReduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorThrombosis Prevention without Anticoagulation.Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation.An essential role of high-molecular-weight kininogen in endotoxemia.The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.Antithrombotic potential of the contact activation pathway.Physiologic activities of the contact activation system.Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation.
P2860
Q28069799-0D121B6D-D276-4C6C-9529-73FC9AB6A6C5Q33671845-8893EAE3-5521-446E-A035-521F9E708D3EQ35004987-E500BA23-F844-4967-98D4-7CDFA0874569Q35104501-0EDA9564-77E1-4871-910D-0F12B89E93A7Q35206857-28295777-0254-4FC8-B86D-B4EC80CA2F9EQ35246390-126B7580-4110-4EE1-9149-4FAEE89CE95DQ37660657-A261ACBA-5D49-4F4B-8A6B-44F67563F8B2Q38287548-C69CF9C7-62EC-4A30-81F3-E3360687A6E0Q38632499-EAEC962A-AAFB-4B6E-953A-0E4526C826FDQ38886826-AB62D782-8870-4D77-819D-9BBC1D9D7058Q39048978-95ADAB11-9DF8-4A4D-91E6-37CE1905224CQ45957917-BC2F5205-A11D-41AB-BDED-107C93FBA848Q47851502-579BC2E5-D07C-4011-9D16-98BA7D9EA58BQ49631904-A4086029-50A1-4BF6-BDD3-FC434E90B6EF
P2860
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@ast
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@en
type
label
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@ast
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@en
prefLabel
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@ast
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@en
P2093
P2860
P1433
P1476
Angiotensin 1-7 and Mas decrea ...... nd glycoprotein VI activation.
@en
P2093
Alec A Schmaier
Alvin H Schmaier
Andrew Chen
Evi Stavrou
Fakhri Mahdi
Gregory N Adams
Gretchen LaRusch
Mariana Morris
Mark Warnock
P2860
P304
P356
10.1182/BLOOD-2012-09-459156
P407
P577
2013-02-05T00:00:00Z